QuantStrategy.io logo
IndicatorsBacktestsFinancialsHistorical PricesPricing

Symbol

Company Info

Company Full Name

Sangamo Therapeutics, Inc.

Full name of the company.

Industry Name

MEDICAL-BIOMED/GENETICS

Industry name

Major Industry Name

DRUGS

Major industry name

Sector Name

Medical

Sector name

Market Info

Current Price

$0.66

Current price of the stock

Trading Volume

$57M

Trading volume of the stock

Market Capitalization

$140.7M

Market capitalization of the company

Market Cap Category

Micro Cap

Category of market capitalization

Long-Term Growth Estimate

27.82%

Long-term growth mean estimate

Analyst Rating Mean

4.43

Mean analyst rating

Potential Upside

661.61%

Potential price appreciation based on analyst price targets

EPS Surprise Percentage Difference

-

Percentage difference of EPS surprise

Dividends

Dividend Change (1 Year)

-

Dividend change over 1 year

Dividend Rate

$0.00

Shows the amount of dividend paid

Balance Sheet

Total Debt to Equity Ratio

-

Total debt to total equity ratio

Current Ratio

1.35

Current ratio

Company Profitability

Gross Profit Margin

100.00%

Gross profit margin

Operating Profit Margin

21.52%

Operating profit margin

EBIT Margin

21.52%

Earnings before interest and taxes (EBIT) margin

EBITDA Margin

-

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin

Pretax Profit Margin

21.78%

Pretax profit margin

Net Profit Margin

21.60%

Net profit margin

Return on Equity (ROE)

27.27%

Measures profitability relative to shareholders' equity

Return on Tangible Equity

27.27%

ROE excluding intangible assets

Return on Assets (ROA)

9.59%

Measures profitability relative to total assets

Return on Invested Capital (ROIC)

27.27%

Measures profitability relative to invested capital

Management Effectiveness

Asset Turnover (quarterly)

0.44

Asset turnover ratio

Inventory Turnover (quarterly)

-

Inventory turnover ratio

Receivables Turnover (quarterly)

4.71

Receivables turnover ratio

Days Sales Outstanding

19.12

Average number of days it takes to collect receivables

Valuation Measures

Price-to-Earnings (P/E) Ratio

-0.86

Measures valuation relative to earnings

Forward P/E Ratio

-1.37

P/E based on future earnings estimates

Price-to-Sales (P/S) Ratio

2.69

Measures valuation relative to sales

Price-to-Book (P/B) Ratio

3.50

Measures valuation relative to book value

Price-to-Operating Cash Flow (P/OCF) Ratio

-0.29

Measures valuation relative to operating cash flow

Price-to-Free Cash Flow (P/FCF) Ratio

-0.28

Measures valuation relative to free cash flow

Cash Flow Statement

Net Acquisitions/Divestitures

0

Indicates company's M&A activity

QuantStrategy.io logo
DisclaimerBlogAbout
Contact UsPrivacyTerms
FacebookTwitter
LinkedinInstagram

© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC